Clinical trial
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity…
NCT00483106 · McGill University, Other · Completed
Key facts
| NCT number | NCT00483106 |
|---|---|
| Title | Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD) |
| Official title | Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD) |
| Lead sponsor | McGill University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Ritalin, Placebo |
| Enrollment | 885 |
| Start date | Nov 1, 1999 |
| Primary completion | Mar 31, 2020 |
| Completion | Mar 31, 2020 |
| First posted | Jun 6, 2007 |
| Last update posted | Mar 16, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: